ReviewCureus2026

Efficacy of Risankizumab in Moderate to Severe Psoriasis Considering Body Mass Index: A Scoping Review.

Karina Sarmiento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.